Prognostic value of tumor infiltrating lymphocyte in metastatic breast cancer

Assessment of PI3KCA immunohistochemical expression and tumor infiltrating lymphocytes (CD4 and CD8) in invasive breast carcinoma and their relation to molecular subtypes

Tumor Infiltrating Lymphocytes Predicting Long-Term Outcomes in HER2-Negative Breast Cancer Patients with Visceral Metastases

Prevalence And Prognostic Value of (TILs) Tumor Infiltrating Lymphocytes in Triple Negative Breast Cancer Patients

Predictive and Prognostic Impact of Tumor-Infiltrating Lymphocytes (CD8+) In Breast Cancer Treated With Neoadjuvant Chemotherapy

Emerging role of the immunotherapy in treatment of breast cancer

COX-2 “Cyclooxygenase 2“as a Prognostic marker in Breast Cancer

Immunohistochemical expression of programmed death-ligand 1 (PD-L1) in invasive duct carcinoma of the breast of no special type and correlation with patients' clinicopathological

Expression of Tumor infiltrating Lymphocytes (Tils), Forkhead Box P3 (FOXP3) and Cyclooxygenase-2 (COX2) in Breast Cancer Patient’s Tumor Tissue, A Single Institute Study

Survival rate and prognosis of single hormone receptor positive breast cancer.